Alan Main
No más puestos en curso
Fortuna: 434 731 $ al 31/05/2024
Perfil
Alan J.
Main served as the President & Chief Executive Officer at Coelacanth Corp.
from 2000 to 2001.
He then worked as the Senior Vice President-US Research at Novartis Pharmaceuticals Corp.
Following that, he held the position of Executive Vice President-Pharmaceutical Research at Lexicon Pharmaceuticals, Inc. from 2007 to 2015.
Dr. Main completed his undergraduate degree at the University of Aberdeen and obtained a doctorate from The University of Liverpool.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2024 | 255 724 ( 0.07% ) | 434 731 $ | 31/05/2024 |
Antiguos cargos conocidos de Alan Main.
| Empresas | Cargo | Fin |
|---|---|---|
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Director Ejecutivo | 01/07/2001 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| LEXICON PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 11/03/2015 |
Formación de Alan Main.
| University of Aberdeen | Undergraduate Degree |
| The University of Liverpool | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Alan Main
